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Background: Obesity associates with low-grade inflammation and adipose tissue remodeling. Using sensitive high-
throughput protein arrays we here investigated adipose tissue cytokine and angiogenesis-related protein profiles
from obese and lean mice, and in particular, the influence of calorie restriction (CR).
Methods: Tissue samples from visceral fat were harvested from obese mice fed with a high-fat diet (60% of energy),
lean controls receiving low-fat control diet as well as from obese and lean mice kept under CR (energy intake 70%
of ad libitum intake) for 50 days. Protein profiles were analyzed using mouse cytokine and angiogenesis protein
array kits.
Results: In obese and lean mice, CR was associated with 11.3% and 15.6% reductions in body weight, as well as
with 4.0% and 4.6% reductions in body fat percentage, respectively. Obesity induced adipose tissue cytokine
expressions, the most highly upregulated cytokines being IL-1ra, IL-2, IL-16, MCP-1, MIG, RANTES, C5a, sICAM-1 and
TIMP-1. CR increased sICAM-1 and TIMP-1 expression both in obese and lean mice. Overall, CR showed distinct
effects on cytokine expressions; in obese mice CR largely decreased but in lean mice increased adipose tissue
cytokine expressions. Obesity was also associated with increased expressions of angiogenesis-related proteins, in
particular, angiogenin, endoglin, endostatin, endothelin-1, IGFBP-3, leptin, MMP-3, PAI-1, TIMP-4, CXCL16, platelet
factor 4, DPPIV and coagulation factor III. CR increased endoglin, endostatin and platelet factor 4 expressions, and
decreased IGFBP-3, NOV, MMP-9, CXCL16 and osteopontin expressions both in obese and lean mice. Interestingly, in
obese mice, CR decreased leptin and TIMP-4 expressions, whereas in lean mice their expressions were increased. CR
decreased MMP-3 and PAI-1 only in obese mice, whereas CR decreased FGF acidic, FGF basic and coagulation factor
III, and increased angiogenin and DPPIV expression only in lean mice.
Conclusions: CR exerts distinct effects on adipocyte cytokine and angiogenesis profiles in obese and lean mice. Our
study also underscores the importance of angiogenesis-related proteins and cytokines in adipose tissue remodeling
and development of obesity.
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Adipose tissue expansion during positive energy balance
is characterized by adipocyte hypertrophy and visceral
adipose tissue accumulation [1,2]. These pathogenic ana-
tomic abnormalities in adipose tissue may trigger meta-
bolic and immune responses that promote obesity-linked
disorders, such as type 2 diabetes, hypertension, dyslipi-
demia and vascular diseases [1,2].
The normal physiological function of white adipose tis-
sue (WAT) is to store the excess energy as neutral trigly-
cerides, from which stored energy can be released for use
at other sites to ensure continuous availability of energy
despite highly variable energy supplies [3]. In addition, adi-
pose tissue is an active endocrine organ that communi-
cates with many other organs through the production of
various secretory proteins, hormones and cytokines that
are collectively referred as adipokines having both pro-
and anti-inflammatory activities [4]. Obesity induces adi-
pose tissue dysfunction, shifting it toward production of
pro-inflammatory adipokines and infiltration of macro-
phages, which eventually leads to the development of
chronic low-grade inflammation [4,5]. This obesity-
induced inflammatory state contributes to systemic meta-
bolic dysfunction that associates with obesity-linked disor-
ders [4,6].
The unique characteristic of adipose tissue is it plasticity
as it continuously undergoes expansion and regression
throughout adult life. Adipose tissue is highly vascularized
organ and therefore the expansion of adipose tissue
requires continuous remodeling of the vascular network
[7-9]. The finding that adipose tissue explants induces
blood vessel formation [10], and in turn adipose tissue
endothelial cells promote preadipocytes differentiation
[11], proves that adipogenesis is linked to angiogenesis.
Furthermore, adipose tissue explants have been utilized
clinically to promote wound healing [12], indicating the
strong angiogenic activity of adipose tissue.
The concomitant occurrence of adipogenesis and angio-
genesis suggests that modulation of angiogenesis may im-
pair adipose tissue development, and thus it could offer a
novel therapeutic option for the treatment of obesity [13].
Anti-angiogenesis agents, including the small chemical
compound TNP-470 and broad-spectrum of endogenous
protein inhibitors, angiostatin and endostatin, have been
shown to prevent genetically and diet-induced obesity in
animals [14,15]. The better understanding the regulation
of pro- and anti-angiogenic components during adipogen-
esis, might provide new targets and approaches for the
treatment of obesity and related metabolic disorders.
In contrast to the excess calorie intake and subsequent
obesity, calorie restriction (CR) effectively ameliorates
the incidence of obesity and related metabolic disorders
[16]. In this study high-fat diet fed C57Bl/6 J mice were
used as model of diet-induced obesity, and cytokine andangiogenesis-related protein profiles were studied be-
tween obese and lean mice using antibody array systems.
In addition, we performed 30% CR for obese and lean
mice and investigated how CR affects protein profiles,
and whether the effects are different between obese and
lean mice.
Materials and methods
Animals and metabolic measurements
Six-week-old male C57Bl/6 J mice were purchased from
Charles River Europe (Sulzfeld, Germany). The animals
were housed 5 per cage in a standard experimental ani-
mal laboratory, illuminated from 07.00 to 19.00 h
(temperature 22 ± 1°C). The protocols were approved by
the Animal Experimentation Committee of the Univer-
sity of Helsinki, Finland and the principles of laboratory
animal care (NIH publication no. 85–23, revised 1985)
were followed. The mice had free access to tap water
during the experiment. After a 1-week acclimatization
period, the mice (n = 6) were fed a high-fat diet (60% of
energy from fat, D05031101M, Research Diets Inc., New
Brunswick, NJ, USA) ad libitum for 100 days to induce
obesity. Lean mice (n = 6) were fed a normal rodent diet
(Harlan Tekland 2018, Harlan Holding, Inc, Wilmington,
DE, USA) ad libitum for 100 days. After 100 days, obese
and lean mice were maintained under calorie restriction
(CR, 70% energy of ad libitum energy intake) for 50 days.
Obese (n = 7) and lean (n = 6) controls were fed a same
high-fat diet (D05031101M) and normal rodent diet ad
libitum, respectively, during the whole experiment for
150 days.
The food consumption was monitored daily and the
body weight once per week by using a standard table
scale (Ohaus Scour™ Pro, SP4001, Nänikon, Switzer-
land). The energy intake was calculated based on the
food consumption and nutritional data. The body fat
content was analyzed by dual-energy x-ray absorpti-
ometry (DEXA, Lunar PIXImus, GE Healthcare, Chal-
font St. Giles, UK) before and after CR.
For oral glucose tolerance test (OGTT), mice were
fasted 6 h and after that glucose were given by gavage
(1 g/kg glucose, 20% glucose solution). Blood glucose
was determined with a glucose metre (Super Gluco-
card™ II, GT-1630, Arkray Factory Inc., Shiga, Japan) on
blood samples taken from the tail vein at time points 0,
15, 30, 60 and 90 min after the gavage. Areas under the
curve (AUC) (blood glucose x time) were calculated.
After the treatment period, the mice were housed in
metabolic cages for 24 h and faeces samples were col-
lected. The faeces were weighted and stored at −70°C
until assayed. The faecal fat content was determined by
Schmid-Bondzynski-Ratzlaff method. The apparent fat
digestibility (%) was determined from fat intake and fae-
cal fat content as described previously [17], using the
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intake− fecal fat content)/fat intake].
At the end of the experiment, the mice were rendered
unconscious with CO2/O2 (95:5% v/v; AGA, Riihimäki,
Finland) and decapitated. The abdominal fat pads were
removed, washed with saline, blotted dried and weighted.
Adipocyte size
Adipocyte cross sectional area was performed as described
in detail elsewhere [18]. Briefly, the fat pads were fixed in
10% formalin and embedded in paraffin with routine tech-
niques. Sections (4 μm) of paraffin-embedded adipose tis-
sue samples were cut with a microtome and mounted on
charged glass, deparaffinized in xylene and stained. The
adipocyte cross-sectional area was determined under a
conventional light microscope (x10 magnification) in a
“blinded” fashion in four fields from each sample (n= 6-7/
group) by Leica QWin Standard-software (Leica Microsys-
tems Imaging Solutions Ltd, Cambridge, UK).
Cytokine and angiogenesis protein analyses
Proteins from abdominal fats (n= 3/group) were isolated
with PBS containing complete protease inhibitors (Roche
Diagnostics, Neuilly-Sur-Seine, France). Fat samples were
homogenized using a Bertin Precellys 24 homogenizer
(Bertin Technologies, Aix en Provence, France), ceramic
beads (Precellys CK14, Bertin Technologies), and a proto-
col consisting of 5000 rpm for 20s repeated twice. Homo-
genized samples containing TritonW X-100 (Sigma, St.
Louis, Mo., USA) with a final concentration of 1% were
frozen at −70°C overnight and centrifuged 10,000 g for
5 min. Protein analysis was performed using mouse cyto-
kine array panel A (represents 40 mouse cytokine pro-
teins) and mouse angiogenesis array kits (represents 53
mouse angiogenesis related proteins) (Proteome Profiler™
antibody arrays, R&D Systems, Inc., MN, USA) according
to the protocol of the manufacturer. Proteins in the 3 sam-
ples (250 μg/sample) from each group were pooled to-
gether and 750 μg of the total protein was used for oneTable 1 Daily energy intake, body weight, body fat percentag
glucose and apparent fat digestibility of obese and lean mice
Obese Obese CR
Daily energy intake (kJ/mouse/day) 61.36 ± 3.40 42.59 ± 0.44a,b
Body weight (g) 42.11 ± 1.40a 37.36 ± 0.61a,b
Body fat (%) 38.54 ± 1.28a 34.54 ± 1.68a,b
Lean body mass (g) 26.47 ± 0.66 24.12 ± 0.44b
AUC blood glucose (mmol*min/ml) 1259.17 ± 147.91a 1074.67 ± 22.8
Apparent fat digestibility (%) 90.66 ± 5.46a 93.81 ± 2.06a
Data is presented as mean ± SEM.
a P < 0.05 compared to lean.
b P < 0.05 compared to obese.membrane. Chemiluminescence solution (ECLplus; Amer-
sham Biosciences, GE Healthcare, Little Chalfont, UK) was
used for protein detection. The protein expression in
membranes was visualized by FLA-9000 fluorescent image
analyzer (Fujifilm, Tokyo, Japan). Proteins were spotted in
duplicates on membranes, and the relative protein expres-
sion between samples was determined by analyzing the
pixel densities of spots in each arrays.
Statistical analysis
Data are presented as means±SEM. Statistically significant
differences in mean values were tested by ANOVA followed
by the Newman-Keuls multiple comparison test. p values
<0.05 were considered statistically significant. GraphPad
Prism, version 4.02 (GraphPad Software, Inc., San Diego,
Calif., USA), was used for the statistical analyses.
Results
Mice characterization and changes in glucose tolerance
and apparent fat digestibility
The daily energy intake did not differ between obese and
lean mice (Table 1). The energy intake of calorie restricted
obese and lean mice was approximately 70% of ad libitum
intake as stated in study plan. The body weight of obese
mice was 1.4-fold higher than in lean mice (Table 1). The
increase in body weight correlated with 2.7-fold increase
in body fat percentage, whereas no difference was seen in
lean body mass between obese and lean mice (Table 1).
CR in obese mice decreased body weight 11.3%, and in
lean mice CR led to 15.6% reduction in body weight. In
obese mice, the body weight loss correlated with 4.0% re-
duction in body fat percentage and 8.9% reduction in lean
body mass. Corresponding values for lean mice were 4.6%
reduction in body fat percentage and 10.1% reduction in
lean body mass.
Oral glucose tolerance was higher in lean mice than in
obese, but CR did not affect oral glucose tolerance (Table
1). The apparent fat digestibility was increased in obese
mice compared to lean mice, and CR in lean micee, lean body mass, area under the curve (AUC) of blood
and mice kept under calorie restriction (CR)
Lean Lean CR N ANOVA p-value
58.60 ± 5.16 37.23 ± 0.22a,b 3 p=0.0013
29.74 ± 0.65 25.11 ± 0.82a,b 12-14 p<0.001
14.17 ± 0.88 9.61 ± 0.39a,b 12-14 p<0.001
25.66 ± 0.63 23.06 ± 0.66a,b 12-14 p=0.0009
8a 722.72 ± 29.30 608.78 ± 27.97b 6 p<0.001
65.12 ± 2.54 76.54 ± 3.21a,b 6-7 p<0.001
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change was seen in obese mice (Table 1).
Adipocyte size
The adipocyte size, measured as adipocyte cross-sectional
area, was significantly higher in obese mice than in lean mice
(Figure 1A, C). Compared to ad libitum fed counterparts,Figure 1 Representative photomicrographs (Original magnification× 1
n=6−7). Data are presented as mean± SEM. * denotes the significant (p<
significant (p< 0.05) difference in comparison with the obese group.CR in obese mice significantly decreased adipocyte size, and
it tended to decrease in lean mice, but the difference did not
reach statistical significance.
Adipose tissue cytokine protein profile
Mouse cytokine array kit was used to analyze the protein
expression of 40 different pro- and anti-inflammatory00) of adipoctytes (A) and adipocyte size shown in histogram (B,
0.05) difference in comparison with the lean group, # denotes the
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MIP-1α were not detected in any study group, and
eotaxin was detected only in calorie restricted lean mice
(Additional file 1: Table S1).
Diet-induced obesity induced cytokine protein expres-
sion, and together 27 cytokines were expressed at higher
level in obese mice as compared to lean controls (Add-
itional file 1: Table S1). The highly expressed proteins
included interleukins IL-1ra, IL-2 and IL-16, chemokines
MCP-1, MIG and RANTES, complement component
C5a, adhesion molecule sICAM-1 and matrix matrix
metallopeptidase inhibitor TIMP-1 (Figure 2).Figure 2 Protein expression of cytokines in adipose tissue of ad libitu
the anti-inflammatory cytokines. * denotes the significant (p< 0.05) differen
(p< 0.05) difference in comparison with the obese group.Cytokine protein profiling revealed that CR in obese
mice decreased the protein expression of 22 proteins and
increased 5 proteins expression (Additional file 1: Table
S1). CR when performed for lean mice showed opposite
effect, and the protein expression of 26 proteins was
increased by CR compared to ad libitum fed lean mice
(Additional file 1: Table S1). Comparison between caloric
restricted mice and ad libitum fed counterparts revealed
that CR highly in obese mice and moderately in lean
mice increased sICAM-1 and TIMP-1 expression (Fig-
ure 2). CR uniquely in obese mice increased IL-16 and
RANTES protein expression and decreased IL-1ram fed or calorie restricted (CR) obese and lean mice. ¤ indicates
ce in comparison with the lean group, # denotes the significant
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in lean mice increased MIG protein expression (Figure 2).
Several CR induced changes were distinct between obese
and lean mice, and CR in obese tended to decrease and
lean mice increase IL-2, MCP-1 and C5a protein expres-
sion (Figure 2).
Adipose tissue angiogenesis protein profiles
Mouse angiogenesis array kit was used to analyze the
protein expression of 53 pro- or anti-angiogenesis pro-
teins in adipose tissue. All proteins were detectable at
least in one study group.
17 proteins were expressed at higher level and 6 proteins
at lower level in obese mice adipose tissue compared to
lean mice (Additional file 2: Table S2). The protein expres-
sion of cell growth regulators angiogenin, endoglin, endo-
statin and endothelin-1 were increased in obese mice
adipose tissue compared to lean mice (Figure 3A). In
addition, the protein expression of angiogenic growth fac-
tors IGFBP-3 and leptin were increased, and FGF basic
was decreased in obese mice compared to lean mice
(Figure 3B). Proteases modulate extracellular matrix and
they have important role in initiation of angiogenesis [19].
The protein expression of protease MMP-3 and protease
inhibitors PAI-1 and TIMP-4 were increased in obese mice
compared to lean mice (Figure 4A). Furthemore, chemo-
kines CXCL16 and platelet factor 4, adhesion molecule
DPPIV and coagulation factor III were higher expressed in
obese than in lean mice, whereas osteopontin was lower
expressed in obese mice than in lean mice (Figure 4B).
Comparison of calorie restricted obese mice with ad libi-
tum fed obese controls showed that 14 proteins were
expressed at lower and 6 proteins at higher level (Add-
itional file 2: Table S2). In lean mice, CR caused major dif-
ferences, and the expression of 32 proteins were increased
and the level of 9 proteins were decreased compared to ad
libitum fed lean mice (Additional file 2: Table S2). 12 of
the highly expressed proteins were detected only in lean
CR group. Cell growth regulators endoglin and endosta-
tin/collagen XVII were increased by CR both in obese and
lean mice (Figure 3A). Angiogenin was uniquely increased
by CR in lean mice (Figure 3A). CR both in obese and lean
mice decreased angiogenic growth factors IGFBP-3 and
NOV protein expression (Figure 3B). Furthermore, CR
uniquely in lean mice decreased FGF acidic and FGF basic
protein expression (Figure 3B). CR had opposite effect on
leptin expression by decreasing leptin expression in obese
mice and increasing expression in lean mice to the level
found in calorie restricted obese mice (Figure 3B).
Proteases were regulated in response to body weight
changes and CR both in obese and lean mice decreased prote-
ase MMP-9 protein expression compared to ad libitum fed
mice (Figure 4A). CR uniquely in obese mice decreased
MMP-3 and PAI-1 protein expression (Figure 4A). Theprotein expression of TIMP-4 was decreased by CR in obese
mice, while in lean mice CR increased expression (Figure 4A).
In addition, CR both in obese and lean mice decreased
CXCL16 and osteopontin expression and increased platelet
factor 4 expression (Figure 4B). CR uniquely in lean mice
increased DPPIV protein expression, and decreased coagula-
tion factor III protein expression compared to ad libitum fed
lean mice (Figure 4B).
Discussion
Accumulating evidence suggests an important role for low-
grade inflammation and adipose tissue remodeling in the
development of obesity. In the present study we investigated
the adipose tissue cytokine and angiogenesis-related protein
profiles from obese and lean mice by using sensitive high-
throughput protein arrays. Furthermore, we examined the
influence of calorie restriction (CR) on adipose tissue pro-
tein profiles. The important finding from the present study
was that obesity is associated with simultaneous induction
of several cytokines and angiogenesis-related proteins in
adipose tissue. CR decreased body weight and body fat per-
centage to a similar extent in obese and lean mice. However,
CR showed opposite effects on protein profiles between
obese and lean mice. CR largely ameliorated cytokine and
angiogenesis-related protein expression in obese mice, while
in lean mice marked upregulation of several proteins was
seen.
Accumulating evidence suggests a close relationship
between the amount of visceral fat, metabolic distur-
bances and cardiovascular diseases [4,6]. Adipose tissue
dysfunction leads abnormal cytokine secretion thus indu-
cing the development of low-grade inflammatory state
that contributes to obesity-linked metabolic disorders
such as type 2 diabetes [4,6]. To study further the mo-
lecular mechanisms mediating adipose tissue inflamma-
tion in obesity, we characterized the cytokine expression
profiles from visceral fat. We were able to demonstrate
that obesity is associated with up-regulation of several
pro-inflammatory cytokines, including IL-1ra, IL-2, IL-
16, MCP-1, MIG, RANTES, C5a and sICAM-1. It is of
great interest that CR in obese mice markedly attenuated
cytokine overexpression, whereas in lean mice CR actu-
ally increased the levels of most of the above mentioned
pro-inflammatory cytokines in the adipose tissue. Dis-
tinct effects of CR on cytokine expression profiles in
obese and lean mice can not been explained by differ-
ences in the study design as both the body weight and
body fat percentage were decreased by CR to a similar
extent in obese and lean mice. Our findings are in good
agreement with the study by Fenton et al. [20] demon-
strating that CR increases serum cytokine levels in lean
mice. Our findings are also consistent with the recent re-
port by Wang et al. [21] showing that CR ameliorates
adipose tissue inflammation in diet-induced obese mice,
Figure 3 Protein expression of angiogenic growth factors (A) and cell growth regulators (B) in adipose tissue of ad libitum fed or
calorie restricted (CR) obese and lean mice. ¤ indicates the anti-angiogenic proteins. * denotes the significant (p< 0.05) difference in
comparison with the lean group, # denotes the significant (p< 0.05) difference in comparison with the obese group.
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of HFD. Further studies are thus warranted to investigate
the cellular mechanisms mediating the opposite effects
of CR on adipose tissue inflammatory response between
obese and lean mice.Adipose tissue is the highly vascularised tissue, and fat
mass expansion is closely linked to angiogenesis [7,8]. Al-
though the cellular mechanisms regulating adipose tissue-
related angiogenesis are still poorly understood, several
pro- and anti-angiogenic components have been identified
Figure 4 Protein expression of proteases and protease inhibitors (A), and chemokines and cell adhesion proteins (B) in adipose tissue
of ad libitum fed or calorie restricted (CR) obese and lean mice. ¤ indicates the anti-angiogenic proteins. * denotes the significant (p< 0.05)
difference in comparison with the lean group, # denotes the significant (p<0.05) difference in comparison with the obese group.
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for adipogenesis, a more deep understanding of the regula-
tion of adipose tissue angiogenesis may provide novel drug
targets for obesity and obesity-related disorders. We there-
fore examined the expression of 53 different pro- and anti-
angiogenic factors in adipose tissue. We were able to dem-
onstrate that obesity is associated with marked alterationsin the protein expression of cell growth regulators, angio-
genic growth factors and proteases as well as their inhibi-
tors. The present study also revealed that CR has a
pronounced modulating effect on adipose tissue protein
expression profiles. However, inclusive nature of our
angiogenic findings should be underlined; we did not per-
form histological analyses to characterize the vasculature,
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ther studies are thus warranted to investigate how the
altered adipose tissue protein expression profiles influence
the vasculature. Furthermore, as obesity has been shown
to alter collagen and elastin expression in adipose tissue
[22], it would be important to examine the influence of CR
on collagen metabolism in future.
Our study showed that leptin was one of the angio-
genic growth factor that is highly sensitive to body
weight changes. Leptin is an adipocyte-derived hormone
that regulates food intake and energy homeostasis. Lep-
tin is also a potent angiogenic factor. Leptin induces
angiogenesis through activation of its own receptor in
endothelial cells leading to activation of Stat3 pathway
and enhancement of its DNA-binding activity [23]. Lep-
tin also indirectly activates angiogenesis by up-regulating
VEGF mRNA expression via activation of the Jak/Stat3
signaling pathway [24]. In addition, leptin has a synergis-
tic effect with FGF basic (also called FGF-2) and VEGF
on stimulation of new blood vessel formation [25]. In the
present study, leptin was high expressed in obese mice
compared to lean mice. Interestingly, higher protein ex-
pression of leptin in obese mice associated with lower
expression of FGF basic, but there was trend toward
increased in PlGF-2 (VEGF homologue) and VEGF-B
(see in supplemental data) protein expression between
obese and lean mice. In obese mice CR down-regulated
leptin expression and up-regulated VEGF expression. In
lean mice the effect of CR on leptin expression was op-
posite; CR up-regulated leptin expression, down-
regulated FGF basic and up-regulated VEGF expression.
These findings indicate distinct effects of CR on adipose
tissue leptin expression between obese and lean mice
and suggest also interaction between leptin, FGF basic
and VEGF family members.
In the present study angiogenic growth factors endo-
statin and endoglin were up-regulated by CR both in
obese and lean mice. Endostatin is an endogenous angio-
genesis inhibitor [26], and treatment with endostatin
reduces body weight of obese mice [14]. Silha et al.
showed recently that plasma levels of vascular growth
factors as well as the angiogenesis inhibitor endostatin
are increased in obese individuals [27]. Endoglin in turn
is a membrane glycoprotein that serves as a receptor for
members of the TGF-β superfamily proteins. It is highly
expressed on proliferating vascular endothelial cells and
it has crucial role in vascular development and disease
[28]. However, the effects of endoglin on adipose tissue
remodeling in obesity are still elusive. In the present
study we demonstrated that endothelin-1 level in the
adipose tissue was increased in obese mice. Previous
studies have revealed that endothelin-1 induces insulin
resistance by suppressing glucose uptake [29,30] and lip-
olysis in adipocytes [31-34] through ETA receptors.Increased plasma endothelin-1 levels have also been
reported in obese subjects with metabolic syndrome [35].
However, the present study revealed that CR does not re-
duce adipose tissue endothelin-1 levels.
Pericellular proteases have been shown to play an import-
ant role in regulating angiogenesis. Proteases participate in
extracellular matrix (ECM) remodeling and in angiogenic
processes by generating pro- and anti-angiogenic factors
from ECM proteins and by processing growth factors and
receptors [19]. Plasminogen activator-plasmin system (fi-
brinolytic system) and matrix metalloproteinases (MMPs)
are two major component of proteolytic system [19]. Plas-
minogen activator inhibitor-1 (PAI-1, also known as serpine
E1) is an inhibitor of fibrinolytic system exerting several
physiological and pathophysiologial effects related to
tumorigenesis, inflammation, thrombosis and metabolic dis-
turbances such as obesity and insulin resistance [36]. Data
from studies investigating the effects of PAI-1 on adipogen-
esis are controversial; some studies using a diet-induced
obese mouse models suggest that PAI-1 deficiency has little
if any effect on the development of obesity [37,38], while
other studies report prevention of obesity and insulin resist-
ance in mice lacking PAI-1 [39]. Furthermore, PAI-1 inhibi-
tor tiplaxtinin has been shown to prevent adipogenesis and
diet-induced obesity [40,41]. In the present study PAI-1 ex-
pression correlated with body weight, and significantly
higher PAI-1 expression were found in obese mice. We also
noticed that CR down-regulated PAI-1 expression only in
obese mice. Our findings thus suggest an important role for
PAI-1 in the development of adipose tissue.
The expression of matrix metallopeptidases (MMPs) in
the adipose tissue were also altered in diet-induced obese
mice. We report here increased MMP-3 expression in
obese mice and down-regulation of MMP-3 in the adi-
pose tissue by CR. It is of great interest that CR down-
regulated MMP-9 expression both in obese and lean
mice, although no difference was detected when the mice
were fed ad libitum. Up-regulation of MMP-3 and
down-regulation of MMP-9 mRNA expression have been
reported recently in expanding adipose tissue [42].
Enhanced adipose tissue development and increased adi-
pose tissue blood vessel density have been demonstrated
in MMP-3 deficient mice kept on high-fat diet [43].
Moreover, MMPs inhibitors have been shown to inhibit
angiogenesis and to reduce body weight in diet-induced
obese mice [14,44-46].
MMPs are inhibited by endogenous tissue inhibitors
(TIMPs), and we here demonstrated upregulation of tis-
sue inhibitors of metalloproteinases TIMP-1 and TIMP-
4 with obesity. CR increased TIMP-1 expression both in
obese and lean mice, whereas TIMP-4 expression was
down-regulated by CR in obese mice and up-regulated in
lean mice. TIMP-1 deficient mice has been shown to
gain less weight and develop less adipose tissue when fed
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levels detected in TIMP-1 deficient mice [47]. These
findings suggest an important role for proteolytic system
in adipose tissue development during diet-induced obes-
ity and during weight reduction induced by CR.
Recent studies suggest an important role for osteopontin
in the development of HFD-induced insulin resistance and,
regulation of vascular and adipose tissue inflammation
[48,49]. Weight loss has been shown to decrease plasma
osteopontin levels [50]. We also demonstrated that CR
decreased adipose tissue osteopontin expression both in
obese and lean mice. Surprisingly, in contrast to some previ-
ous studies [50,51], we were unable to demonstrate obesity-
induced osteopontin overexpression in the adipose tissue.
Finally, we here reported increased expression of CXCL16
in obese mice. Furthermore, we were able to demonstrate
that CR decreased adipose tissue CXCL16 expression both
in lean and obese mice. Previous studies have linked
CXCL16 and its receptor CXCR6 to inflammation-
associated cancers [52], renal fibrosis [53], and vascular in-
flammatory diseases, such as atherosclerosis [54]. Further
studies are warranted to investigate the role of CXCL16/
CXCR6 axis in adipose tissue remodeling.
Conclusion
Using diet-induced obese mice as experimental model of
obesity we here demonstrate that obesity is associated with
induction of several cytokines and angiogenesis-related pro-
teins in the adipose tissue. Although calorie restriction
decreased body weight and body fat percentage to a similar
extent in obese and lean mice, the influence of CR on adi-
pose tissue protein profiles was largely opposite; whereas
CR ameliorated cytokine and angiogenesis-related protein
expression in obese mice, we noticed an upregulation of
several proteins by CR in lean mice. These findings support
the notion of modulating adipose tissue cytokines and/or
angiogenesis-related proteins to ameliorate the development
of obesity. The present study also suggests that CR might
exert detrimental effects on adipose tissue remodeling in
lean mice.
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